Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03407794
Other study ID # 10334264-2
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 7, 2018
Est. completion date April 16, 2021

Study information

Verified date November 2022
Source University of North Florida
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This proposal will examine whether daily consumption of fermented vegetables for 6 weeks can impact the gut microflora and markers of inflammation of women between the ages of 18-70 years.


Description:

Interested participants will be invited to an orientation where study procedures will be explained in detail. Once the consent form is signed participants will schedule a visit to provide blood, urine and stool samples at the beginning of the intervention at which point they will be randomized into one of three groups: a fermented vegetable group (1/2 cup per day for 6 weeks), a non-fermented vegetable group (1/2 cup per day for 6 weeks) and a control group (usual diet). Both vegetable groups will receive weekly deliveries of the vegetables to be consumed. Following 6 weeks, participants will provide blood, urine and stool samples one more time. Participants will also fill out questionnaires related to dietary intake, demographics, physical activity, prescription medication use and gastrointestinal function. Compliance will be monitored weekly via a gastrointestinal function log where participants will be asked to enter whether they consumed or not the vegetable provided each day, as well as any side effects of consumption.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date April 16, 2021
Est. primary completion date August 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - BMI: 18.5-40 kg/m2 - Non-smoker - No previous diagnosis of cancer - No thyroid disease - No diabetes - Willing to consume 1/2 cup of vegetables daily for 6 weeks - No use of psychotic or depression medication - No medication to lose weight - Not on a weight loss diet - No use of antibiotics over the past 3 months - No consumption of fermented vegetables on a regular basis - No history of autoimmune disease, including gastrointestinal disease Exclusion Criteria: - BMI <18.5 or >40 kg/m2 - Smoker - Taking medications that affect appetite or body weight - Uncontrolled Hypertension - Diabetes - Not willing to consume 1/2 cup of vegetables daily for 6 weeks - Willing to show up at two appointments - Following a fad diet - Using antibiotics frequently - Diagnosed with autoimmune disease, like psoriasis, rheumatoid arthritis, thyroid disease, colitis - Regular consumption of fermented vegetables

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Fermented vegetable
The intervention is to consume 1/2 cup fermented vegetables every day for 6 weeks
Non-fermented vegetable
The intervention is to consume 1/2 cup of non-fermented vegetables every day for 6 weeks

Locations

Country Name City State
United States University of North Florida Jacksonville Florida

Sponsors (2)

Lead Sponsor Collaborator
University of North Florida University of Arkansas

Country where clinical trial is conducted

United States, 

References & Publications (2)

Han K, Bose S, Wang JH, Kim BS, Kim MJ, Kim EJ, Kim H. Contrasting effects of fresh and fermented kimchi consumption on gut microbiota composition and gene expression related to metabolic syndrome in obese Korean women. Mol Nutr Food Res. 2015 May;59(5):1004-8. doi: 10.1002/mnfr.201400780. Epub 2015 Mar 23. — View Citation

Kim EK, An SY, Lee MS, Kim TH, Lee HK, Hwang WS, Choe SJ, Kim TY, Han SJ, Kim HJ, Kim DJ, Lee KW. Fermented kimchi reduces body weight and improves metabolic parameters in overweight and obese patients. Nutr Res. 2011 Jun;31(6):436-43. doi: 10.1016/j.nutres.2011.05.011. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary C-reactive Protein Marker of systemic inflammation: serum CRP 6 weeks
Primary Shannon Index The Shannon Index is a measure of diversity of microbial species that takes into account both abundance (the number of species present) and evenness (how close the numbers for each species are). The Shannon index can be calculated using the following equation: H= -?(i=1)^s pi ln(pi). A value of zero for H indicates that a community has only one species. The higher the value of H, the higher the diversity of species in a particular community. 6 weeks
Secondary BMI Measured using a multifrequency bioimpedance scale 6 weeks
Secondary Body Fat Percentage Measured using a multifrequency bioimpedance scale 6 weeks
Secondary Systolic Blood Pressure Measured using an electronic blood pressure cuff 6 weeks
Secondary Lipopolysaccharide Marker of inflammation in serum 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT03995979 - Inflammation and Protein Restriction N/A
Completed NCT03255187 - Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT03577223 - Egg Effects on the Immunomodulatory Properties of HDL N/A
Completed NCT04383561 - Relationship Between LRG and Periodontal Disease N/A
Active, not recruiting NCT03622632 - Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
Completed NCT06216015 - Exercise Training and Kidney Transplantation N/A
Completed NCT04856748 - Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
Completed NCT05529693 - Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population N/A
Recruiting NCT05670301 - Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases N/A
Recruiting NCT05415397 - Treating Immuno-metabolic Depression With Anti-inflammatory Drugs Phase 3
Recruiting NCT04543877 - WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study Early Phase 1
Recruiting NCT05775731 - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Completed NCT03859934 - Metabolic Effects of Melatonin Treatment Phase 1
Completed NCT03429920 - Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors N/A
Completed NCT06065241 - Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals. N/A
Completed NCT05864352 - The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
Completed NCT03318731 - Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males N/A
Not yet recruiting NCT06134076 - Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota N/A
Not yet recruiting NCT06159543 - The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes N/A